Ryan Fukushima Sells 3,500 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) COO Ryan Fukushima sold 3,500 shares of the business’s stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $40.23, for a total transaction of $140,805.00. Following the transaction, the chief operating officer now directly owns 1,003,707 shares of the company’s stock, valued at approximately $40,379,132.61. This represents a 0.35 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Ryan Fukushima also recently made the following trade(s):

• On Wednesday, December 11th, Ryan Fukushima sold 120,000 shares of Tempus AI stock. The stock was sold at an average price of $42.51, for a total transaction of $5,101,200.00.

Tempus AI Stock Down 12.0 %

NASDAQ TEM traded down $4.66 on Wednesday, reaching $34.29. 7,396,915 shares of the company’s stock traded hands, compared to its average volume of 1,521,735. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $79.49. The stock has a 50-day moving average price of $52.24. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.

Institutional Investors Weigh In On Tempus AI

Institutional investors have recently made changes to their positions in the business. NEA Management Company LLC bought a new position in Tempus AI during the 2nd quarter worth approximately $160,048,000. Novo Holdings A S purchased a new position in shares of Tempus AI in the second quarter worth $142,605,000. Revolution Growth Management Company Inc. bought a new stake in Tempus AI during the 2nd quarter valued at $128,133,000. ARK Investment Management LLC boosted its position in Tempus AI by 355.0% during the 3rd quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock valued at $134,604,000 after buying an additional 1,855,459 shares during the period. Finally, Alphabet Inc. bought a new stake in Tempus AI in the 2nd quarter worth $54,289,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Wall Street Analysts Forecast Growth

TEM has been the topic of several research analyst reports. Piper Sandler reaffirmed a “neutral” rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Loop Capital raised their price target on Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a report on Tuesday, October 15th. Guggenheim initiated coverage on Tempus AI in a research report on Monday, December 9th. They set a “buy” rating and a $74.00 price target for the company. Bank of America upped their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research report on Friday, December 13th. Finally, Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and lifted their target price for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $56.00.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.